S&P/IHS Markit: OPIS Faces Spin-Off; Cappitech Beefs Up Regtech Frontline

Commonalities between the two firms' commodities pricing units bring them under regulatory scrutiny as they move closer to an acquisition deal. At the same time, it appears that IHS will lean into the regulatory reporting space.


As S&P Global Market Intelligence sets out to acquire IHS Markit by the second half of this year, some analysts, including those advising on the deal, say S&P will need to divest itself of OPIS, IHS Markit’s energy and commodities pricing business, to satisfy anti-trust laws.

The proposed deal would bring together several complementary businesses, including combining S&P’s equities index unit with IHS Markit’s fixed-income index offering; and S&P’s artificial intelligence (AI) research platform

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Waterstechnology? View our subscription options

Systematic tools gain favor in fixed income

Automation is enabling systematic strategies in fixed income that were previously reserved for equities trading. The tech gap between the two may be closing, but differences remain.

Why recent failures are a catalyst for DLT’s success

Deutsche Bank’s Mathew Kathayanat and Jie Yi Lee argue that DLT's high-profile failures don't mean the technology is dead. Now that the hype has died down, the path is cleared for more measured decisions about DLT’s applications.

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here